You are not currently logged in
| Local | |
| GMT |
Results: 16289
Merck & Co fails to convince U.S. court to dismiss Fosamax osteonecrosis claims 09/09/2009 16:43 GMT (Score: 0)- COPD: Boehringer’s Spiriva may have different effects depending on the other drugs administered 09/09/2009 15:43 GMT (Score: 0)
- Almirall to file COPD treatment aclidinium bromide for European approval 09/09/2009 14:41 GMT (Score: 0)
- Study highlights efficacy of Stallergenes’ Oralair for hayfever allergy 09/09/2009 13:58 GMT (Score: 0)
- Vivus announces positive Phase III results of weight-loss drug Qnexa 09/09/2009 13:47 GMT (Score: 0)
- Pfizer to cut 90 jobs in Italy, half in clinical research 09/09/2009 13:46 GMT (Score: 0)
- AOK says slow start will not stop discount contracts producing target savings 09/09/2009 13:32 GMT (Score: 0)
- Sanofi-Aventis researchers protest over group restructuring plan 09/09/2009 13:28 GMT (Score: 0)
- Sanofi Pasteur MSD's Gardasil approved for use EU in women up to 45 09/09/2009 13:01 GMT (Score: 0)
- Report suggests NHS is fully utilising NICE-approved drugs 09/09/2009 12:38 GMT (Score: 0)
- Novo formally launches Victoza, dismissive of competitor Byetta 09/09/2009 11:00 GMT (Score: 0)
- Novartis’ Lucentis less effective when requested by patients - study 09/09/2009 10:11 GMT (Score: 0)
- Bayer discounts Nexavar in liver cancer but NICE still rejects it 09/09/2009 10:06 GMT (Score: 0)
- Recordati enters bidding for Poland’s Polfa Pabiance 09/09/2009 09:48 GMT (Score: 0)
- Respiratory tract infections: antibiotic treatment depends on procalcitonin level 09/09/2009 09:40 GMT (Score: 0)
1 of 1086
